BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26890773)

  • 1. Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    Bonet-Costa V; Herranz-Pérez V; Blanco-Gandía M; Mas-Bargues C; Inglés M; Garcia-Tarraga P; Rodriguez-Arias M; Miñarro J; Borras C; Garcia-Verdugo JM; Viña J
    J Alzheimers Dis; 2016; 51(3):701-11. PubMed ID: 26890773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
    Cramer PE; Cirrito JR; Wesson DW; Lee CY; Karlo JC; Zinn AE; Casali BT; Restivo JL; Goebel WD; James MJ; Brunden KR; Wilson DA; Landreth GE
    Science; 2012 Mar; 335(6075):1503-6. PubMed ID: 22323736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
    Mandrekar-Colucci S; Karlo JC; Landreth GE
    J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
    Bagheri M; Joghataei MT; Mohseni S; Roghani M
    Neurobiol Learn Mem; 2011 Mar; 95(3):270-6. PubMed ID: 21144907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
    Liu RT; Tang JT; Zou LB; Fu JY; Lu QJ
    Eur J Pharmacol; 2011 Nov; 669(1-3):76-83. PubMed ID: 21872584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
    Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
    J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
    Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
    Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.
    Balducci C; Paladini A; Micotti E; Tolomeo D; La Vitola P; Grigoli E; Richardson JC; Forloni G
    J Alzheimers Dis; 2015; 46(2):471-82. PubMed ID: 25777514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
    Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
    Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule TBTC as a new selective retinoid X receptor α agonist improves behavioral deficit in Alzheimer's disease model mice.
    Sun Y; Fan J; Zhu Z; Guo X; Zhou T; Duan W; Shen X
    Eur J Pharmacol; 2015 Sep; 762():202-13. PubMed ID: 26026644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.
    Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM
    Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.
    Arélin K; Kinoshita A; Whelan CM; Irizarry MC; Rebeck GW; Strickland DK; Hyman BT
    Brain Res Mol Brain Res; 2002 Jul; 104(1):38-46. PubMed ID: 12117549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical success against Alzheimer's disease with an old drug.
    LaFerla FM
    N Engl J Med; 2012 Aug; 367(6):570-2. PubMed ID: 22873540
    [No Abstract]   [Full Text] [Related]  

  • 20. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.